How does the paragraph IV certification process relate to USPTO disclosures?
The paragraph IV certification process, typically associated with generic drug applications to the FDA, can generate information material to patentability that should be disclosed to the USPTO. According to MPEP 2015: “Consequently, to assist USPTO staff in evaluating patentability effectively and efficiently, the party receiving a paragraph IV certification should review such documents to determine…
Read MoreWhen is there no duty to disclose information to the USPTO?
According to the MPEP Section 2001.05, there is generally no duty to disclose information to the United States Patent and Trademark Office (USPTO) when: The information is clearly cumulative to information already of record or being made of record in the application, or The information is clearly not material. The MPEP states: “Generally, when information…
Read MoreHow can applicants meet the duty of disclosure requirement?
Applicants can meet the duty of disclosure requirement by submitting information to the USPTO in the manner prescribed by 37 CFR 1.97 and 1.98. The MPEP states: “37 CFR 1.56 provides that the duty of disclosure can be met by submitting information to the Office in the manner prescribed by 37 CFR 1.97 and 1.98.”…
Read MoreHow does the USPTO define “material to patentability” in the context of information disclosure?
How does the USPTO define “material to patentability” in the context of information disclosure? The USPTO defines “material to patentability” in the context of information disclosure through 37 CFR 1.56(b). The MPEP states: “Information is material to patentability when it is not cumulative to information already of record or being made of record in the…
Read MoreWhat is the significance of the phrase “material to patentability” in relation to copending applications?
What is the significance of the phrase “material to patentability” in relation to copending applications? The phrase “material to patentability” is crucial when considering information from copending applications. According to MPEP 2001.06(b): “The information from the copending application may be material to patentability of the application in question.” This means that any information from a…
Read MoreHow does MPEP 2001.06(b) define “material to patentability” for copending applications?
How does MPEP 2001.06(b) define “material to patentability” for copending applications? According to MPEP 2001.06(b), information is considered “material to patentability” of a copending application if: It could be used in rejecting a claim in the copending application It meets the definition of materiality in 37 CFR 1.56(b) It contradicts or is inconsistent with a…
Read MoreWhat is considered material information under 37 CFR 1.56(b)?
According to 37 CFR 1.56(b), information is material to patentability when: It is not cumulative to information already of record or being made of record in the application, and It either: Establishes, by itself or in combination with other information, a prima facie case of unpatentability of a claim; or Refutes, or is inconsistent with,…
Read MoreWhat types of information from litigation are considered material to patent examination?
According to MPEP 2001.06(c), several types of information from litigation are considered material to patent examination: Evidence of possible prior public use or sales Questions of inventorship Prior art references Allegations of fraud, inequitable conduct, or violation of duty of disclosure Assertions made during litigation that contradict statements made to the examiner Defenses raised against…
Read MoreWhat is considered ‘material information’ in the context of the duty of disclosure?
‘Material information’ in the context of the duty of disclosure refers to any information that is relevant to the patentability of an invention. This includes prior art, public disclosures, or any other information that could affect the decision of a patent examiner or the Patent Trial and Appeal Board (PTAB). While MPEP 2001.03 does not…
Read MoreHow does market testing and commercialization information relate to patent disclosures?
Market testing, marketing, and commercialization activities can produce information material to patentability that should be disclosed to the USPTO. The MPEP 2015 states: “Activities or documents associated with market testing, marketing, or commercialization by the patent applicant can also be material to patentability, and therefore, when material, should be disclosed to the USPTO.” This requirement…
Read More